Keywords: APTC; Antiplatelet Trialists' Collaboration; ATE; arterial thromboembolic event; CBV; cerebrovascular; CI; confidence interval; CV; cardiovascular; EPAR; European Public Assessment Report; ICD-9-CM; International Classification of Diseases, Ninth Revision
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; DME; diabetic macular edema; DR; diabetic retinopathy; DRSS; Diabetic Retinopathy Severity Scale; ETDRS; Early Treatment Diabetic Retinopathy Study; HbA1c; hemoglobin A1c; NPDR; nonproliferative diabe
Keywords: AV; arteriovenous; BCVA; best-corrected visual acuity; BRAVO; RanibizumaB for the treatment of macular edema following bRAnch retinal Vein Occlusion; BRVO; branch retinal vein occlusion; BVOS; Branch Vein Occlusion Study; CFT; central foveal thickness; CP
Keywords: AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; CST; central subfield thickness; OCT; optical coherence tomography; PRN; pro re nata; RBZ; ranibizumab; R
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE
Keywords: BCVA; best-corrected visual acuity; CST; central subfield thickness; DA; disc area; DME; diabetic macular edema; DR; diabetic retinopathy; ETDRS; Early Treatment for Diabetic Retinopathy Study; FA; fluorescein angiogram; FAZ; foveal avascular zone; MNP; m
Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study)
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; DA; disc area; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysis set; HbA1C; glycated hemoglobin; HR-PDR; high-risk proliferative diabetic retinopathy;
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study
Keywords: BCVA; best-corrected visual acuity; CFT; central foveal thickness; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; FDA; Food and Drug Administration; OCT; optical coherence tomography; PRN; pro re nata; RBZ; ranibizumab; RE
Neutralization of Vascular Endothelial Growth Factor Slows Progression of Retinal Nonperfusion in Patients with Diabetic Macular Edema
Keywords: BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; DA; disc area; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; RBZ; ranibizumab; RNP; retinal nonperfusion; RVO; retinal vein occlusion; VEGF; vascu